NASDAQ · UHS
Healthcare · Medical - Care Facilities
$176.05
Down-$0.56 (-0.32%)
Updated Nov 2, 2026, 10:03 AM
SID Score
5.7/10
Composite research score
Smart Money
58/100
Neutral
Price performance · UHS
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 30, 2026
UHS closed at $176.05 after 20 trading sessions, up 0.00% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 30, 2026 | $179.44 | $179.44 | $175.15 | $176.05 | 582.1K |
| Oct 29, 2026 | $174.20 | $176.92 | $170.32 | $176.61 | 1.01M |
| Oct 28, 2026 | $175.00 | $182.35 | $169.125 | $172.18 | 1.51M |
| Oct 27, 2026 | $187.32 | $191.58 | $173.83 | $177.32 | 1.25M |
| Oct 26, 2026 | $186.89 | $189.34 | $184.81 | $185.71 | 721K |
| Oct 23, 2026 | $187.27 | $188.98 | $186.565 | $186.89 | 450.8K |
| Oct 22, 2026 | $183.36 | $188.86 | $182.94 | $188.13 | 489.33K |
| Oct 21, 2026 | $184.81 | $187.38 | $182.44 | $182.87 | 338.47K |
| Oct 20, 2026 | $184.10 | $187.36 | $183.07 | $185.61 | 340.56K |
| Oct 19, 2026 | $183.89 | $186.11 | $180.79 | $182.29 | 547.64K |
| Oct 16, 2026 | $188.57 | $189.19 | $182.715 | $185.10 | 585.57K |
| Oct 15, 2026 | $189.61 | $190.55 | $187.26 | $187.36 | 490.42K |
| Oct 14, 2026 | $180.08 | $186.90 | $179.9693 | $185.89 | 656.34K |
| Oct 13, 2026 | $179.57 | $179.755 | $177.765 | $179.01 | 653.66K |
| Oct 12, 2026 | $177.56 | $181.20 | $177.235 | $178.83 | 558.3K |
| Oct 9, 2026 | $175.31 | $178.63 | $174.74 | $177.35 | 397.33K |
| Oct 8, 2026 | $173.39 | $177.20 | $173.39 | $175.72 | 429.23K |
| Oct 7, 2026 | $175.83 | $178.13 | $174.19 | $174.62 | 540.29K |
| Oct 6, 2026 | $174.21 | $178.11 | $174.21 | $177.08 | 412.39K |
| Oct 5, 2026 | $175.42 | $178.25 | $175.42 | $176.05 | 580.15K |
The latest Smart Investors Daily articles mentioning UHS.
Company
Market Activity
Research & News
UHS research
Company profile and research snapshot.
Universal Health Services Inc owns and operates acute care hospitals, behavior health centers, surgical hospitals, ambulatory surgery centers, and radiation oncology centers. The firm operates in two segments: Acute Care Hospital Services and Behavioral Health Services. The company generates the majority of its revenue from the Acute Care Hospital Services segment. The Acute Care Hospital Services segment includes the firm's acute care hospitals, surgical hospitals, and surgery and oncology centers.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Oct 29, 2026 | Baird | Neutral | — |
| Oct 29, 2026 | Guggenheim | Buy | — |
| Sep 18, 2026 | Leerink Partners | Outperform | — |
| Aug 20, 2026 | RBC Capital | Sector Perform | — |
| Aug 3, 2026 | RBC Capital | Sector Perform | — |
No generated briefing is available yet.
Yahoo · Oct 31, 2026
Hospital management company Universal Health Services (NYSE:UHS) met Wall Street’s revenue expectations in Q3 2026, with sales up 5.3% year on year to $4.73 billion. Its non-GAAP profit of $5.22 per share was 1.3% above analysts’ consensus estimates.
Yahoo · Oct 30, 2026
KING OF PRUSSIA, Pa., Oct. 30, 2026 (GLOBE NEWSWIRE) -- Universal Health Services, Inc. (NYSE: UHS) is scheduled to present at the UBS Global Healthcare Conference on November 10, 2026, at 9:30 a.m. Eastern Time. A live audio webcast of the presentation and a webcast replay will be available at the Investor Relations section of the Company’s website (www.uhsinc.com). About Universal Health Services Headquartered in King of Prussia, PA, UHS is one of the nation’s largest and most respected provid
Yahoo · Oct 30, 2026
UHT's third-quarter 2026 earnings and FFO improve year over year, driven by lower depreciation and interest costs amid steady revenues.
Yahoo · Oct 30, 2026
The updated analyst narrative for Universal Health Services reflects a slightly lower Fair Value Estimate of US$189.94, down from US$194.35, as refreshed assumptions work through new price target models. Recent commentary around quarterly results, revised 2026 guidance, one off items near US$200m, and sector wide elective surgery softness helps explain why some analysts are trimming while others remain more constructive. As you read on, you will see how to track these moving pieces and follow...
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning UHS.
